- $37.29m
- $35.93m
- $54.01m
- 50
- 46
- 77
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49.8 | 75.4 | 75.8 | 69.2 | 54 |
Cost of Revenue | |||||
Gross Profit | 22.9 | 35.9 | 35.1 | 23.3 | 22.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 66.9 | 82.4 | 130 | 154 | 82.6 |
Operating Profit | -17.1 | -6.99 | -53.7 | -84.6 | -28.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.9 | -10.5 | -71.7 | -79.3 | -32.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.9 | -10.5 | -71.7 | -79.3 | -32.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.9 | -10.5 | -71.7 | -79.3 | -32.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.9 | -10.5 | -71.7 | -79.3 | -37.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.22 | -1.31 | -9.05 | -9.98 | -4.53 |
Dividends per Share |